These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 22877431)

  • 1. Glucocorticoid-induced osteoporosis and osteonecrosis.
    Weinstein RS
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):595-611. PubMed ID: 22877431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in treatment of glucocorticoid-induced osteoporosis.
    Hsu E; Nanes M
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):411-417. PubMed ID: 28857847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teriparatide therapy for denosumab-induced osteonecrosis of the jaw in a male osteoporotic patient.
    Neuprez A; Rompen E; Crielaard JM; Reginster JY
    Calcif Tissue Int; 2014 Jul; 95(1):94-6. PubMed ID: 24804929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.
    Chotiyarnwong P; McCloskey EV
    Nat Rev Endocrinol; 2020 Aug; 16(8):437-447. PubMed ID: 32286516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced osteonecrosis.
    Weinstein RS
    Endocrine; 2012 Apr; 41(2):183-90. PubMed ID: 22169965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone and glucocorticoids.
    Briot K
    Ann Endocrinol (Paris); 2018 Jun; 79(3):115-118. PubMed ID: 29685453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments.
    Lane NE
    Curr Osteoporos Rep; 2019 Feb; 17(1):1-7. PubMed ID: 30685820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of glucocorticoid induced osteoporosis].
    Arazzi M; Di Fulvio G; Di Pietro LO; Grabocka X; Longo MO; Micioni G; Pezzutto A; Piscitani L; Schiazza A; Silvestri S; Vigilante G; Amoroso L; Bonomini M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?
    Teitelbaum SL; Seton MP; Saag KG
    Arthritis Rheum; 2011 Feb; 63(2):325-8. PubMed ID: 21279986
    [No Abstract]   [Full Text] [Related]  

  • 10. Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs.
    Iwamoto N; Okamoto M; Tsuji S; Endo Y; Takatani A; Shimizu T; Umeda M; Fukui S; Sumiyoshi R; Igawa T; Koga T; Kawashiri SY; Aramaki T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Eguchi K; Ueki Y; Kawakami A
    J Bone Miner Metab; 2019 May; 37(3):554-562. PubMed ID: 30187273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-induced osteoporosis: management update.
    Adler RA
    Curr Osteoporos Rep; 2010 Mar; 8(1):10-4. PubMed ID: 20425085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab in the treatment of glucocorticoid-induced osteoporosis.
    Coskun Benlidayi I
    Rheumatol Int; 2018 Nov; 38(11):1975-1984. PubMed ID: 30019224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis.
    Chiodini I; Falchetti A; Merlotti D; Eller Vainicher C; Gennari L
    Expert Rev Endocrinol Metab; 2020 Jul; 15(4):283-298. PubMed ID: 32584619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
    Bultink IE; Baden M; Lems WF
    Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.
    Mazziotti G; Giustina A; Canalis E; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1404-12. PubMed ID: 18209880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-induced osteoporosis.
    Silverman SL; Lane NE
    Curr Osteoporos Rep; 2009 Mar; 7(1):23-6. PubMed ID: 19239826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health.
    Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG
    J Am Acad Dermatol; 2017 Jan; 76(1):1-9. PubMed ID: 27986132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid induced osteoporosis.
    Hu K; Adachi JD
    Expert Rev Endocrinol Metab; 2019 Jul; 14(4):259-266. PubMed ID: 31094232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid-induced osteoporosis: an update.
    Mazziotti G; Angeli A; Bilezikian JP; Canalis E; Giustina A
    Trends Endocrinol Metab; 2006; 17(4):144-9. PubMed ID: 16678739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.